How does 22nd Century Group's performance compare to other tobacco and nicotineâreduction companies in the sector?
Based on the information you provided, the only detail available about 22ndâŻCenturyâŻGroup (tickerâŻXXII) is that the company will release its secondâquarterâŻ2025 earnings onâŻAugustâŻ14,âŻ2025 (press release atâŻ6:00âŻAMâŻET, webcast atâŻ8:00âŻAMâŻET). No financial results, operating metrics, or comparative data are included in the announcement.
What we can conclude from the current news
| Item | Detail |
|---|---|
| Announcement | 22ndâŻCenturyâŻGroup will publish its Q2âŻ2025 results onâŻAugustâŻ14,âŻ2025. |
| Sector positioning | The company describes itself as âthe only tobaccoâproducts company that has for 27âŻyears led and continues to lead the fight against the harms of smoking driven by nicotine addiction.â This underscores a focus on reducedârisk or ânicotineâreductionâ products rather than traditional combustible cigarettes. |
| Performance data | None â the press release does not contain revenue, earnings, margins, cashâflow, shareâprice movement, or any other quantitative performance indicators. |
Why a performance comparison isnât possible at this time
- No disclosed results â The announcement is purely a schedule for the upcoming earnings release; it contains no numbers to compare (e.g., revenue growth, earnings per share, adjusted EBITDA, market share, etc.).
- Lack of peer data â The news item does not mention any other tobacco or nicotineâreduction companies (e.g., Altria, PhilipâŻMorris International, JUUL Labs, Reynolds American, BritishâŻAmericanâŻTobacco, SwedishâŻMatch, or newer reducedârisk firms). Therefore, there is no benchmark information provided.
- Timing â Until the Q2âŻ2025 results are actually released (and possibly analystsâ commentary or peerâgroup earnings summaries are published), any assessment would be speculative.
How you can obtain a meaningful comparison once the results are out
When the Q2âŻ2025 results are published, you can compare 22ndâŻCenturyâŻGroupâs performance to peers using the following typical metrics:
| Metric | Why it matters | Typical peerâgroup sources |
|---|---|---|
| Revenue (and YoY growth) | Indicates topâline demand for reducedârisk products. | Company earnings releases, SEC filings, marketâresearch reports (e.g., Euromonitor, IRI). |
| Net income / EPS | Shows profitability after all expenses. | Same as above; also Bloomberg/FactSet consensus EPS. |
| Adjusted EBITDA margin | Helps assess operating efficiency, stripping out nonârecurring items. | Analyst presentations, earnings call transcripts. |
| Cash flow from operations | Reflects ability to fund R&D, acquisitions, or dividend/repurchase programs. | Quarterly cashâflow statements. |
| Shareâprice performance | Market perception of growth prospects relative to peers. | Stock price charts, totalâreturn indices for the tobacco sector. |
| Productâmix shifts (e.g., percentage of revenue from nicotineâreduction vs. conventional products) | Directly ties to the companyâs âharmâreductionâ positioning. | Management commentary, product pipeline updates. |
| Regulatory milestones (e.g., FDA authorizations) | Can be a catalyst for growth in the reducedârisk space. | FDA databases, company press releases. |
Once you have those numbers for 22ndâŻCenturyâŻGroup, you can line them up against similarly focused companies such as:
- Altria Group (MO) â especially its âreducedâriskâ portfolio (e.g., IQOS, VEEV).
- PhilipâŻMorris International (PM) â with its âheatânotâburnâ IQOS platform.
- JUUL Labs (private/owned by Altria) â a leading eâcigarette brand.
- BritishâŻAmericanâŻTobacco (BTI) â with its âVypeâ and other vapor products.
- Reynolds American (now part of BritishâŻAmericanâŻTobacco) â developing nicotineâpouch and vaping products.
- SwedishâŻMatch â a pure-play nicotineâreduction company with snus and nicotine pouches.
Bottom line
From the current pressâreleaseâonly information, we cannot assess how 22ndâŻCenturyâŻGroupâs performance stacks up against other tobacco and nicotineâreduction companies. To make a comprehensive comparison, you will need to wait for the actual Q2âŻ2025 earnings data (revenue, earnings, margins, cash flow, etc.) and then juxtapose those figures with the same period results of peer companies. Once that data is available, a sideâbyâside analysis using the metrics listed above will provide the insight youâre looking for.